Zeit | Aktuelle Nachrichten | Rating | Leser | ||
---|---|---|---|---|---|
06.03. | Greggs - Performing well in a challenging market | 288 | FY24 was a good year for Greggs as its long-term strategy to grow revenue, coupled with more favourable input cost inflation, provided better profit growth than in FY23. In common with many consumer... ► Artikel lesen | ||
05.03. | Team Internet Group - Rebasing for Google Adsense transition | 391 | We are re-initiating forecasts on Team Internet to reflect Verdane's decision not to make an offer for the business (removing Take Over Panel research restrictions) and the company's trading update... ► Artikel lesen | ||
05.03. | IRLAB Therapeutics (OMX: IRLAB-A) misses primary endpoint with pirepemat | 276 | IRLAB Therapeutics has announced top-line results from the Phase IIb REACT-PD study evaluating its second most clinically advanced asset, pirepemat, as a potential treatment for falls related to Parkinson's... ► Artikel lesen | ||
05.03. | Cantargia (OMX: CANTA) reports positive CAN10 update | 258 | Cantargia has reported encouraging pharmacokinetic data from the first cohort in the multiple ascending dose portion of the CAN10 study. Importantly, the data align with the single dose portion of the... ► Artikel lesen | ||
05.03. | Verve Group - Strong Q4 with good momentum into FY25 | 521 | Verve delivered a strong Q424, with organic net revenue growth of 24%, and resultant progress for the full year of 36% to €437m, clearly outstripping our modelled €420m. The group's focus on ID-less... ► Artikel lesen | ||
05.03. | Oryzon (BME: ORY) publishes results of vafidemstat in PMS | 281 | Oryzon Genomics has announced the publication of a study in Frontiers in Psychiatry, which explores the potential of vafidemstat in Phelan-McDermid Syndrome (PMS). PMS is a form of autism whereby agitation... ► Artikel lesen | ||
05.03. | SIG (LSE: SHI) - FY24 results in line; outlook H2 biased | 261 | SIG confirmed FY24 revenue of £2.6bn (FY23: £2.8bn) and operating profit of £25.1m (FY23: £53.1m), in line with January's FY24 trading update. Although full-year like-for-like revenue declined by 4%... ► Artikel lesen | ||
05.03. | Foxtons (LSE: FOXT) - FY24 results ahead of expectations; confident outlook | 305 | Foxtons' FY24 results were modestly ahead of guidance, with revenue up 11% to £163.9m and operating profit up 38% to £21.6m (FY23; £15.7m on a revised basis). Although Lettings and Financial Services... ► Artikel lesen | ||
05.03. | Freelancer Limited - Q424 results point to stronger FY25 | 296 | Freelancer reported FY24 results that confirmed that the core Freelancer marketplace saw improved customer acquisition and retention in Q424, providing positive momentum going into FY25. With a streamlined... ► Artikel lesen | ||
05.03. | Games Workshop Group (LSW: GAW) trading ahead of expectations | 363 | Games Workshop Group has issued a brief update that trading for both core and licensing was ahead of expectations in January and February 2025 and that profit for the year will be ahead of expectations.... ► Artikel lesen | ||
05.03. | Gresham House Energy Storage Fund - Proceeding as planned | 273 | Gresham House Energy Storage Fund (GRID), the UK's largest listed fund investing in utility-scale battery energy storage systems (BESS), has released a trading update ahead of the publication of its... ► Artikel lesen | ||
04.03. | Reach - Reach for the stars | 310 | Reach's FY24 results were ahead of market expectations after a strong Q4, with a return of the digital segment to growth for the full year and a resilient performance in the print assets against a structurally... ► Artikel lesen | ||
04.03. | Zalaris - Raising margin guidance | 230 | Zalaris reported another record quarter of revenue and operating profit. In constant currency (cc), the company reported revenue growth of 13.6% y-o-y in Q424 and 16.1% in FY24, helped by strong growth... ► Artikel lesen | ||
04.03. | PCI-Pal (LSE: PCIP) new partnership with RingCentral | 235 | PCI-Pal reported H125 revenue of £10.57m (+26% y-o-y, +13% excluding deferred revenue adjustment), adjusted EBITDA of £0.95m (H124: -£0.07m) and adjusted EBIT of £0.18m (H124: -£0.73m). Exit ARR increased... ► Artikel lesen | ||
04.03. | Oryzon Genomics - All steady heading into 2025 | 276 | Oryzon has reported its FY24 results, reflecting steady progress across its pipeline. Oryzon's highest value-driving programme remains vafidemstat in borderline personality disorder (BPD), which, following... ► Artikel lesen | ||
04.03. | Cairn Homes - Underlying demand supports confident outlook | 327 | Cairn Homes' FY24 results were robust and it has issued even more challenging targets for FY25. The Irish housing market remains undersupplied, which bodes well for its future, supported by government... ► Artikel lesen | ||
04.03. | Greggs (LSE:GRG) - 11% growth in FY24 revenue and underlying EPS | 293 | Greggs' FY24 results confirm its multi-year growth strategy continues to deliver good results. The increasingly challenging macroeconomic conditions in Q424 were flagged in its January trading statement... ► Artikel lesen | ||
03.03. | Creo Medical - Refreshed business outlook | 193 | Creo Medical has released its FY24 trading update, summarising an eventful year for the company and its strategic priorities. The period saw Creo reaffirm its focus on its core technology platform and... ► Artikel lesen | ||
03.03. | Severfield (LON: SFR) - Headwinds still blowing | 272 | Severfield's markets have remained 'challenging' in the period since the interims, with pricing remaining tighter for longer than expected and clients cancelling or deferring decisions. However, the... ► Artikel lesen | ||
28.02. | Pan American Silver - Finishing the year on a strong note | 932 | Pan American Silver (PAAS) reported FY24 revenues and EBITDA of US$2.8bn and US$1.0bn, up 22% and 51% y-o-y, respectively. The company achieved record net operating and free cash flows of US$724m and... ► Artikel lesen | ||
28.02. | dotDigital - Quality evident in H125 results | 256 | Despite economic pressures in Dotdigital Group's end markets, the H125 results showed that the management team has put the group in a good position to take advantage of the current (and expected continued)... ► Artikel lesen | ||
28.02. | IAG (LSE:IAG) FY24 results above consensus expectations | 303 | IAG has delivered an impressive set of results for 2024, with a 26.7% increase in operating profit before exceptional items to €4,443 million and a strengthened operating margin of 13.8%. This performance... ► Artikel lesen | ||
28.02. | Rightmove's (LSE: RMV) continued enhancements are paying off | 302 | Rightmove continues to grow by adding value to its offering via technological improvements, increasingly with AI-driven enhancements, rather than simply being reflective of the health of the housing... ► Artikel lesen | ||
27.02. | Borussia Dortmund - Requiring more Bundesliga points in H225 | 424 | Borussia Dortmund's (BVB's) Q225 results were mainly influenced by the phasing of games in the competitions in which it is competing. The phasing is not unusual but has been accentuated this year by... ► Artikel lesen | ||
27.02. | IRLAB (OMX: IRLAB-A) publishes Phase IIb mesdopetam results in journal | 240 | IRLAB Therapeutics has announced that the results from its Phase IIb clinical trial, evaluating mesdopetam as a potential treatment to address levodopa induced dyskinesias, have been published in the... ► Artikel lesen |